BTMD PE Ratio & Valuation,Is BTMD Overvalued

BTMD Relative Valuation

BTMD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BTMD is overvalued; if below, it's undervalued.

Historical Valuation

Biote Corp (BTMD) is now in the Fair zone, suggesting that its current forward PS ratio of 0.45 is considered Fairly compared with the five-year average of 4.01. The fair price of Biote Corp (BTMD) is between 1.57 to 4.55 according to relative valuation methord.

Relative Value

Fair Zone

1.57-4.55

Current Price：2.65

Fair

11.41

3.59

EV/EBITDA

Biote Corp. (BTMD) has a current EV/EBITDA of 3.59. The 5-year average EV/EBITDA is 2.29. The thresholds are as follows: Strongly Undervalued below -0.87, Undervalued between -0.87 and 0.71, Fairly Valued between 3.86 and 0.71, Overvalued between 3.86 and 5.44, and Strongly Overvalued above 5.44. The current Forward EV/EBITDA of 3.59 falls within the Historic Trend Line -Fairly Valued range.

5.40

EV/EBIT

Biote Corp. (BTMD) has a current EV/EBIT of 5.40. The 5-year average EV/EBIT is 3.22. The thresholds are as follows: Strongly Undervalued below -1.25, Undervalued between -1.25 and 0.98, Fairly Valued between 5.45 and 0.98, Overvalued between 5.45 and 7.69, and Strongly Overvalued above 7.69. The current Forward EV/EBIT of 5.40 falls within the Historic Trend Line -Fairly Valued range.

0.45

Biote Corp. (BTMD) has a current PS of 0.45. The 5-year average PS is 0.53. The thresholds are as follows: Strongly Undervalued below -0.10, Undervalued between -0.10 and 0.22, Fairly Valued between 0.85 and 0.22, Overvalued between 0.85 and 1.17, and Strongly Overvalued above 1.17. The current Forward PS of 0.45 falls within the Historic Trend Line -Fairly Valued range.

2.93

P/OCF

Biote Corp. (BTMD) has a current P/OCF of 2.93. The 5-year average P/OCF is 2.77. The thresholds are as follows: Strongly Undervalued below -0.58, Undervalued between -0.58 and 1.10, Fairly Valued between 4.44 and 1.10, Overvalued between 4.44 and 6.12, and Strongly Overvalued above 6.12. The current Forward P/OCF of 2.93 falls within the Historic Trend Line -Fairly Valued range.

3.47

P/FCF

Biote Corp. (BTMD) has a current P/FCF of 3.47. The 5-year average P/FCF is 3.11. The thresholds are as follows: Strongly Undervalued below -0.37, Undervalued between -0.37 and 1.37, Fairly Valued between 4.86 and 1.37, Overvalued between 4.86 and 6.60, and Strongly Overvalued above 6.60. The current Forward P/FCF of 3.47 falls within the Historic Trend Line -Fairly Valued range.

Biote Corp (BTMD) has a current Price-to-Book (P/B) ratio of -1.14. Compared to its 3-year average P/B ratio of -2.57 , the current P/B ratio is approximately -55.61% higher. Relative to its 5-year average P/B ratio of -2.08, the current P/B ratio is about -45.10% higher. Biote Corp (BTMD) has a Forward Free Cash Flow (FCF) yield of approximately 39.47%. Compared to its 3-year average FCF yield of 15.76%, the current FCF yield is approximately 150.40% lower. Relative to its 5-year average FCF yield of 12.84% , the current FCF yield is about 207.45% lower.

-1.11

P/B

Median3y

-2.57

Median5y

-2.08

39.47

FCF Yield

Median3y

15.76

Median5y

12.84

Competitors Valuation Multiple

The average P/S ratio for BTMD's competitors is , providing a benchmark for relative valuation. Biote Corp Corp (BTMD) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of -6.67%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of BTMD decreased by 57.61% over the past 1 year. The primary factor behind the change was an decrease in Revenue Growth from 51.38M to 47.96M.

The secondary factor is the Margin Expansion, contributed -21.97%to the performance.

Overall, the performance of BTMD in the past 1 year is driven by Revenue Growth. Which is more sustainable.

-6.67%

51.38M → 47.96M

Revenue Growth

-21.97%

24.63 → 19.22

Margin Expansion

-28.97%

4.74 → 3.37

P/E Change

-57.61%

6.18 → 2.62

Mkt Cap Growth

People Also Watch

Frequently Asked Questions

Is Biote Corp (BTMD) currently overvalued or undervalued?

What is Biote Corp (BTMD) fair value?

BTMD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Biote Corp (BTMD) is between 1.57 to 4.55 according to relative valuation methord.

How does BTMD's valuation metrics compare to the industry average?

What is the current P/B ratio for Biote Corp (BTMD) as of Dec 16 2025?

As of Dec 16 2025, Biote Corp (BTMD) has a P/B ratio of -1.14. This indicates that the market values BTMD at -1.14 times its book value.

What is the current FCF Yield for Biote Corp (BTMD) as of Dec 16 2025?

As of Dec 16 2025, Biote Corp (BTMD) has a FCF Yield of 39.47%. This means that for every dollar of Biote Corp’s market capitalization, the company generates 39.47 cents in free cash flow.

What is the current Forward P/E ratio for Biote Corp (BTMD) as of Dec 16 2025?

As of Dec 16 2025, Biote Corp (BTMD) has a Forward P/E ratio of 11.76. This means the market is willing to pay $11.76 for every dollar of Biote Corp’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Biote Corp (BTMD) as of Dec 16 2025?

As of Dec 16 2025, Biote Corp (BTMD) has a Forward P/S ratio of 0.45. This means the market is valuing BTMD at $0.45 for every dollar of expected revenue over the next 12 months.

BTMD Valuation